Repository

Publications

Liposomal irinotecan for previously treated patients with biliary tract cancer: A pooled analysis of NIFTY and NALIRICC trials

Yoo C, Saborowski A, Hyung J, Wenzel P, Kim I, Wege H, Kim K, Folprecht G, Ryoo B, Schütt P, Cheon J, Götze T, Ryu H, Lee J, Vogel A
Journal of Hepatology. 2025 Mar 25. doi: 10.1016/j.jhep.2025.03.013
2025 

Deciphering the spatial tumor microenvironment in intrahepatic cholangiocarcinoma

Macias RIR, Roessler S, Verstegen MMA
Hepatology. 2025 Mar 24. doi: 10.1097/HEP.0000000000001322
2025 

Mutational Analysis of Bile Cell-Free DNA in Primary Sclerosing Cholangitis: A Pilot Study

Arechederra M, Bik E, Rojo C, Elurbide J, Elizalde M, Kruk B, Krasnodębski M, Pertkiewicz J, Kozieł S, Grąt M, Raszeja-Wyszomirska J, Rullan M, Alkorta-Aranburu G, Oyón D, Fernández-Barrena M, Candels L, Białek A, Krupa Ł, Schneider K, Urman J, Strnad P, Trautwein C, Milkiewicz P, Krawczyk M, Ávila M, Berasain C
Liver Int . 2025 Apr;45(4):e70049. doi: 10.1111/liv.70049.
2025 

Understanding Cholangiocarcinoma—perspectives from three European advocacy groups

Baucells E, Morement H, Leonardi P
Lancet Regional Health Europe. 2025 Feb 19. DOI: 10.1016/j.lanepe.2025.101239
2025 

New systemic treatment paradigms in advanced biliary tract cancer and variations in patient access across Europe

Rimassa L, Lamarca A, O'Kane G, Edeline J, McNamara M, Vogel A, Fassan M, Forner A, Kendall T, Adevar J, Casadei-Gardini A, Fornaro L, Hollebecque A, Lowery M, Macarulla T, Malka D, Mariamidze E, Niger M, Ustava A, Bridgewater J, Macias RIR, Braconi C
Lancet Regional Health Europe. 2025 Feb 19. DOI: 10.1016/j.lanepe.2024.101170
2025 
Join the Action
JOIN